Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCEAN
NCT04986982Phase 4Completed
- Sponsor
- BIAL
- Start
- Feb 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of opicapone in Parkinson's disease (PD), sponsored by BIAL. Started Feb 2021; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04986982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04986982.